Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma
Clinical trial NCT03510416 · UNKNOWN
Trial details
- NCT number
- NCT03510416
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2019-06-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.